Clinical Trials Logo
  1. Home
  2. Overactive Detrusor
  3. NCT01408771

"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver

Overactive Detrusor Clinical Trial

Official title:
"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver

Clinical Trial Summary

The purpose of this study is to find out whether swallowing has an effect on the degree of urinary urgency and on the amplitude of detrusor contraction during filling cystometry in patients with detrusor overactivity (DO).

Clinical Trial Description

Consecutive patients with DO will be included in this study. During urodynamics, the amplitude of the waves of DO will be documented and compared. At the beginning of the 2nd wave, patients will be asked to perform 5 repetitive swallows. Following each wave, patients will be asked to grade the severity of the urgency by a visual analogue scale (VAS). ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01408771
Study type Observational
Source Assaf-Harofeh Medical Center
Contact
Status Completed
Phase N/A
Start date April 2011
Completion date July 2011
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05977634 - Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder N/A
Completed NCT02657057 - Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB N/A
Completed NCT01192568 - Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder Phase 4
Completed NCT01837654 - Plantarflexion Reduces Urgency and Peak Detrusor Pressure in Patients With Detrusor Overactivity N/A
Completed NCT03451175 - Reproductibility of Cystometry in Multiple Sclerosis Patient N/A
Terminated NCT03080389 - Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections
Completed NCT01629433 - Onabotulinumtoxina Intradetrusorial Injections and NGF Expression Phase 4
Completed NCT01781117 - Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia N/A
Terminated NCT00845338 - Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity Phase 2
Completed NCT03388086 - Efficacy of Two Onabotulinum Toxin Doses
Completed NCT04197466 - Comparison of Different Treatments for Overactive Bladder Syndrome N/A
Not yet recruiting NCT02009540 - Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity Phase 4
Completed NCT04270526 - Minimizing Pain During Office Intradetrussor Botox Injection Phase 4
Enrolling by invitation NCT06212661 - Migraine Medication Effects on Urinary Symptoms
Recruiting NCT05895045 - Yoga for Treatment of Overactive Bladder in Pediatric Patients N/A